Changes in Hong Kong stocks | Shenwei Pharmaceutical (02877) soared 12% in the afternoon, the first half of the year's results fell by more than 20% and plans to pay a second interim dividend of 80 points

The Zhitong Finance App learned that Shenwei Pharmaceutical (02877) soared 12% in the afternoon. As of press release, it had risen 8% to HK$8.57, with a turnover of HK$36.224,300.

According to the news, Shenwei Pharmaceutical announced interim results, with a turnover of RMB 1,181 billion for the first half of the year, a year-on-year decrease of 28.5%; profit for the period of 469 million yuan, a year-on-year decrease of 23.7%; basic profit per share of 62 points; and plans to pay a second interim dividend of 80 points.

According to the announcement, the Group's overall gross margin fell to 69.9% from 72.2% in the same period last year due to declining sales scale and price cuts brought about by centralized procurement, as well as high production costs. The Group continues to focus its development strategy on expanding oral formulations. In the first six months of 2026, oral products accounted for 72.9% of total sales, while injectable products accounted for 27.1% of total sales.